Genetic and genomic testing will continue to grow in importance. But, pricing and reimbursement challenges persist and impede uptake. While precision medicine has the capacity to revolutionize clinical practice, payers need to be on board with coverage of diagnostics in order to make this a reality.
Genomic Diagnostic Tests Face Persistent Pricing And Reimbursement Challenges
